THE CLINICAL-SIGNIFICANCE OF HIGH ANTI-GM 1 ANTIBODIES IN ACUTE GUILLAIN-BARRE-SYNDROME

Citation
E. Sindern et al., THE CLINICAL-SIGNIFICANCE OF HIGH ANTI-GM 1 ANTIBODIES IN ACUTE GUILLAIN-BARRE-SYNDROME, Aktuelle Neurologie, 22(4), 1995, pp. 136-139
Citations number
13
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
03024350
Volume
22
Issue
4
Year of publication
1995
Pages
136 - 139
Database
ISI
SICI code
0302-4350(1995)22:4<136:TCOHA1>2.0.ZU;2-9
Abstract
Anti-GM1 IgG and IgM antibodies were measured in the serum of 20 patie nts with acute Guillain-Barre Syndrome (GBS) and compared with anti-GM 1 antibody activity in patients with herpes tester, meningoradiculitis Bannwarth, different chronic polyneuropathies and in healthy voluntee rs. We found high IgG anti-GM1 antibodies (titre > 1:6400) only in 3 G BS patients (15%). AU three patients had preceeding diarrhoea and sero logical evidence of Campylobacter jejuni enteritis. At the maximum of the illness they were tetraplegic or tetraparetic with no sensory defi cits. Half a year later one had a good recovery, one was wheel-chair b ound and one remained bedridden. Electrophysiological examination reve aled evidence of demyelination early in the disease. Later secondary a xonal damage was found. IgG anti-GM1 antibodies may define a subgroup of GBS patients with severe motor neuropathy that is frequently associ ated with preceeding C. jejuni enteritis.